1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N1380S2
    Guaiacol-13C6

    愈创木酚-13C6

    Guaiacol-13C613C 标记的 Guaiacol。 Guaiacol 是一种酚类化合物,抑制 LPS 刺激的 COX-2 表达和 NF-κB 激活。具有抗炎活性。
    Guaiacol-<sup>13</sup>C<sub>6</sub>
  • HY-142958
    NF-κB-IN-2
    NF-κB-IN-2 抑制TNF-α诱导的PC-3细胞中的典型NF-κB信号传导。
    NF-κB-IN-2
  • HY-168328
    FKK6 Inhibitor
    FKK6 是孕烷 X 受体 (PXR) 的选择性激动剂,EC50 为 1.2 µM。FKK6 与血浆蛋白具有良好的亲和性,并且在人类微粒体中具有良好的代谢特性。FKK6 抑制 PXR 相关的 NF-κB 信号通路,抑制炎症因子的表达,并在小鼠模型中对 DSS (HY-116282) 诱发的结肠炎表现出抗炎活性。
    FKK6
  • HY-149248
    NF-κB-IN-8 Inhibitor
    NF-κB-IN-8 竞争性拮抗 LPS 与 MD-2 的结合。NF-κB-IN-8 通过与 MD-2 结合来降低炎症因子的表达。NF-κB-IN-8 也抑制 ALP 活性。NF-κB-IN-8 可用于急性肺损伤 (ALI) 等炎症疾病的研究。
    NF-κB-IN-8
  • HY-117616
    Laurotetanine Inhibitor
    Laurotetanine ((+)-Laurotetanine) 是一种口服有效的异喹啉类生物碱,可从 Litsea cubeba (Lour.) Pers 的根中提取。Laurotetanine 通过下调 MUC5ACNF-κB 信号通路抑制 IgE、组胺和炎症反应发挥抗哮喘作用。
    Laurotetanine
  • HY-B0808R
    Oxaprozin (Standard)

    奥沙普秦 (标准品)

    Inhibitor
    Oxaprozin (Standard) 是 Oxaprozin 的分析标准品。本产品用于研究及分析应用。 Oxaprozin 是一种口服有效的 COX 的抑制剂,其对人类血小板COX-1IL-1 刺激的人类滑膜细胞 COX-2IC50 值分别为 2.2 和 36 μM。Oxaprozin 还能抑制 NF-κB 的活化。Oxaprozin 诱导细胞凋亡 (apoptosis)。Oxaprozin 具有抗炎活性。Oxaprozin 介导的 Akt/IKK/NF-κB 通路抑制有助于其抗炎特性。
    Oxaprozin (Standard)
  • HY-162510
    SPDZi1 Inhibitor
    SPDZi1 是一种强效且选择性的 syntenin 抑制剂,可与 syntenin 的 PDZ1PDZ2 域结合。SPDZi1 与 syntenin PDZ 串联 (STNPDZ) 结合,Kd 为 3.6 μM。SPDZi1 抑制胶质母细胞瘤并降低 NF-κB(syntenin 的下游效应物)的活性。
    SPDZi1
  • HY-139844
    Anti-inflammatory agent 7 Inhibitor
    Anti-inflammatory agent 7 通过阻断 LPS 处理的 RAW 264.7 细胞和小鼠的 NF-κB/MAPK 信号通路抑制促炎细胞因子。
    Anti-inflammatory agent 7
  • HY-126026
    NF-κB-IN-17 Inhibitor
    NF-κB-IN-17 (Zinc5) 是 NF-κB 的抑制剂。NF-κB-IN-17 抑制 TNF-α 诱导的 C2C12 细胞 NF-κB DNA 结合活性。
    NF-κB-IN-17
  • HY-144744
    NF-κB-IN-3 Inhibitor
    NF-κB-IN-3 (Compound 2) 是一种 NF-κB 抑制剂,IC50 值为 0.70 µM。NF-κB-IN-3 可用作抗肿瘤剂。
    NF-κB-IN-3
  • HY-B0678S1
    Metaxalone-d6

    美他沙酮-d6

    Inhibitor
    Metaxalone-d6 是 Metaxalone 氘代物。Metaxalone (AHR438; NSC170959) 是 FDA 批准的一种肌肉松弛剂。Metaxalone 主要作用于中枢神经系统,通过抑制多突触反射弧达到肌肉松弛的效果。此外,Metaxalone 是 MAO-A 的抑制剂,具有抗炎和抗氧化的作用。Metaxalone 在 IL-1β 处理的小胶质细胞中,可抑制 IL-1β 诱导的炎症表型,调节 NF-κB 等相关信号通路以及降低 MAO-A 表达和活性。
    Metaxalone-d<sub>6</sub>
  • HY-N0119R
    Naringin Dihydrochalcone (Standard)

    柚皮苷二氢查尔酮 (Standard)

    Inhibitor
    Naringin Dihydrochalcone (Standard) 是 Naringin Dihydrochalcone 的分析标准品。本产品用于研究及分析应用。Naringin Dihydrochalcone是由柚皮苷衍生的人造甜味剂。 柚皮苷是从番茄,葡萄柚和许多其他柑橘类水果中获得的主要黄烷酮糖苷。 柚皮素表现出抗氧化,抗炎和抗细胞凋亡等生物活性。Naringin 可抑制 NF-κB 信号通路。
    Naringin Dihydrochalcone (Standard)
  • HY-161627
    Anemoside A3-methyl 6-aminohexanoate Inhibitor
    Anemoside A3-methyl 6-aminohexanoate (Compound A3-6) 是 Pulchinenoside C (Anemoside B4) (HY-N0205) 的衍生物。Anemoside A3-methyl 6-aminohexanoate 抑制丙酮酸羧化酶 (pyruvate carboxylase,PC) (IC50 为 0.058 μM),重新编程巨噬细胞功能,并通过抑制 NF-κBNLRP3 炎症小体通路缓解 DSS 诱发的结肠炎。Anemoside A3-methyl 6-aminohexanoate 与 Anemoside B4 相比,表现出中等的体内药代动力学特征。
    Anemoside A3-methyl 6-aminohexanoate
  • HY-N0802R
    Tenuigenin (Standard)

    远志皂苷元 (Standard)

    Inhibitor
    Tenuigenin (Standard) 是 Tenuigenin 的分析标准品。本产品用于研究及分析应用。Tenuigenin 是从中草药远志 (Polygala tenuifolia) 根中分离出来的主要活性成分。Tenuigenin 通过抑制 NF-κB 活化来预防金黄色葡萄球菌诱导的肺炎。
    Tenuigenin (Standard)
  • HY-N0716R
    Berberine (Standard)

    黄连素 (Standard)

    Inhibitor
    Berberine (Standard)是 Berberine 的分析标准品。本产品用于研究及分析应用。Berberine (Natural Yellow 18) 是从中草药黄连中分离出来的一种生物碱,常用作抗生素。Berberine (Natural Yellow 18) 诱导活性氧 (ROS) 生成并抑制 DNA 拓扑异构酶 (topoisomerase)。Berberine (Natural Yellow 18) 具有抗肿瘤特性。硫酸盐形式 (HY-N0716B) 可提高
    Berberine (Standard)
  • HY-B0513R
    Methylthiouracil (Standard)

    甲硫氧嘧啶 (Standard)

    Inhibitor
    Methylthiouracil (Standard) 是 Methylthiouracil 的分析标准品。本产品用于研究及分析应用。Methylthiouracil 是一种抗甲状腺剂。Methylthiouracil 抑制 TNF-αIL-6 的产生以及 NF-κBERK1/2 的活化。
    Methylthiouracil (Standard)
  • HY-149331
    TNF-α-IN-11 Inhibitor
    TNF-α-IN-11 (Compound 10) 是一种 TNF-α 抑制剂,KD 值为 12.06 μM。 TNF-α-IN-11 与 TNF-α 结合并阻断 TNF-α 触发的 caspaseNF-κB 信号通路的激活。TNF-α-IN-11 抑制 IκBα 的磷酸化以及 NF κB p65 的核转位。TNF-α-IN-11 可用于 TNF-α 介导的自身免疫性疾病的研究。
    TNF-α-IN-11
  • HY-N6032
    Esculentoside B Inhibitor
    Esculentoside B (Phytolaccoside B) 是来源于 Phytolacca acinosa Roxb 根部的天然产物。Esculentoside B 对斑马鱼幼鱼具有神经毒性,并损害其中枢神经系统发育。Esculentoside B 抑制炎症反应,具有抗真菌 (antifungal) 活性。
    Esculentoside B
  • HY-N11892
    7-O-Methylaloesinol Inhibitor
    7-O-Methylaloesinol 是一种色素衍生物。7-O-Methylaloesinol 对 TNF-α 诱导的 NF-κB 转录活性有显著抑制作用,IC50 值为 29.07 μM。
    7-O-Methylaloesinol
  • HY-N7182
    9,10-Dimethoxycanthin-6-one Inhibitor
    9,10-Dimethoxycanthin-6-one 是一种生物碱化合物,具有 NF-κB 抑制作用,IC50 为 19.5 μM。
    9,10-Dimethoxycanthin-6-one
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.